Molecular characterization of beta 1,4-galactosyltransferase 7 genetic mutations linked to the progeroid form of Ehlers-Danlos syndrome (EDS)

Catherine Bui, Ibtissam Talhaoui, Matthieu Chabel, Guillermo Mulliert, Michael W. H. Coughtrie, Mohamed Ouzzine, Sylvie Fournel-Gigleux

    Research output: Contribution to journalArticlepeer-review

    17 Citations (Scopus)


    beta 1,4-Galactosyltransferase 7 (beta 4GalT7) is a key enzyme initiating glycosaminoglycan (GAG) synthesis. Based on in vitro and ex vivo kinetics studies and structure-based modelling, we molecularly characterized beta 4GalT7 mutants linked to the progeroid form of Ehlers-Danlos syndrome (EDS), a severe connective tissue disorder. Our results revealed that loss of activity upon L206P substitution due to altered protein folding is the primary cause for the GAG synthesis defect in patients carrying the compound A186D and L206P mutations. We showed that R270C substitution strongly reduced beta 4GalT7 affinity towards xyloside acceptor, thus affecting GAG chains formation. This study establishes the molecular basis for beta 4GalT7 defects associated with altered GAG synthesis in EDS. (C) 2010 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

    Original languageEnglish
    Pages (from-to)3962-3968
    Number of pages7
    JournalFEBS Letters
    Issue number18
    Publication statusPublished - 24 Sep 2010


    • Ehlers-Danlos syndrome
    • Point mutation
    • Galactosyltransferase defect
    • Glycosaminoglycan synthesis
    • Congenital glycosyltransferase disorder
    • Galactosyltransferase-I beta4GalT-7
    • Heparan sulfate
    • Protein
    • Biosynthesis
    • Proteoglycan
    • Fibroblasts
    • Expression
    • Patient
    • Binding
    • Identification

    Cite this